Circulating cardiac biomarkers and postoperative atrial fibrillation in the OPERA trial

Eur J Clin Invest

9 November Nov 2015 10 years ago
  • Masson S, Wu JH, Simon C, Barlera S, Marchioli R, Mariani J, Macchia A, Lombardi F, Vago T, Aleksova A, Dreas L, Favaloro RR, Hershson AR, Puskas JD, Dozza L, Silletta MG, et al; OPERA Investigators. Cavallotti L, Myasoedova V tra i collaboratori
QR Code
Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery and predicts increased morbidity and mortality. Identification of patients at high risk of POAF with the help of circulating biomarkers may enable early preventive treatment but data are limited, especially in contemporary surgical patients.